Our modern facility in Tijuana offers reliable, continuous stock of authentic brand-name GLP-1 therapies under rigorous physician supervision, available at a small fraction of retail U.S
CT-388 is a long-acting GLP-1/GIP dual agonist designed for weekly subcutaneous injection
Description Overview of Dream Spray Intranasal Research Formula Product Information: This intranasal research preparation is designed to assist with sleep, circadian rhythm, and neuroendocrine signalling related to the biological clock
Regulatory Toxicology and Pharmacology, 114 , 104665
For an insulin syringe (U-100 scale, 100 units = 1 mL): For published preclinical context: mouse studies (Billon 2023, PMID 37739806) used 25 mg/kg IP twice daily a much higher per-kilogram dose than community injectable users typically describe
Symptoms include headache, hunger, sweating, irritability, dizziness, nausea, and feeling anxious or shaky